Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 4
1915 1
1916 1
1917 2
1918 1
1919 3
1920 1
1923 1
1927 1
1931 1
1933 1
1934 1
1941 1
1946 1
1947 3
1948 1
1950 3
1951 3
1952 3
1953 5
1955 8
1956 5
1957 2
1958 2
1959 3
1960 8
1961 4
1962 3
1963 5
1964 5
1965 2
1966 1
1967 3
1968 1
1969 2
1970 1
1972 1
1973 2
1974 3
1975 1
1976 1
1977 4
1978 2
1981 1
1983 1
1984 3
1985 5
1986 1
1987 2
1988 4
1989 5
1990 5
1991 1
1992 6
1993 1
1994 4
1995 3
1996 2
1998 2
2000 4
2001 2
2002 5
2003 2
2005 2
2006 1
2010 2
2012 3
2013 1
2014 1
2015 2
2016 5
2017 5
2018 6
2019 8
2020 11
2021 13
2022 17
2023 12
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, Chong SG, MacIsaac S, Assayag D, Johannson KA, Fell CD, Marcoux V, Manganas H, Morisset J, Comes A, Fisher JH, Shapera S, Gershon AS, To T, Wong AW, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Cox G, Richeldi L, Ryerson CJ, Kolb M. Hambly N, et al. Among authors: fisher jh. Eur Respir J. 2022 Oct 6;60(4):2102571. doi: 10.1183/13993003.02571-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35273032 Free article.
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease.
Goobie GC, Carlsten C, Johannson KA, Khalil N, Marcoux V, Assayag D, Manganas H, Fisher JH, Kolb MRJ, Lindell KO, Fabisiak JP, Chen X, Gibson KF, Zhang Y, Kass DJ, Ryerson CJ, Nouraie SM. Goobie GC, et al. Among authors: fisher jh. JAMA Intern Med. 2022 Dec 1;182(12):1248-1259. doi: 10.1001/jamainternmed.2022.4696. JAMA Intern Med. 2022. PMID: 36251286 Free PMC article.
Update in Interstitial Lung Disease 2019.
Montesi SB, Fisher JH, Martinez FJ, Selman M, Pardo A, Johannson KA. Montesi SB, et al. Among authors: fisher jh. Am J Respir Crit Care Med. 2020 Aug 15;202(4):500-507. doi: 10.1164/rccm.202002-0360UP. Am J Respir Crit Care Med. 2020. PMID: 32412784 Free PMC article. Review. No abstract available.
In Response.
Flexman AM, Roughead T, Fisher JH, Sewell D, Ryerson CJ. Flexman AM, et al. Among authors: fisher jh. Anesth Analg. 2017 May;124(5):1742-1743. doi: 10.1213/ANE.0000000000002035. Anesth Analg. 2017. PMID: 28426590 No abstract available.
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
Marinescu DC, Hague CJ, Muller NL, Murphy D, Churg A, Wright JL, Al-Arnawoot A, Bilawich AM, Bourgouin P, Cox G, Durand C, Elliot T, Ellis J, Fisher JH, Fladeland D, Grant-Orser A, Goobie GC, Guenther Z, Haider E, Hambly N, Huynh J, Johannson KA, Karjala G, Khalil N, Kolb M, Leipsic J, Lok S, MacIsaac S, McInnis M, Manganas H, Marcoux V, Mayo J, Morisset J, Scallan C, Sedlic T, Shapera S, Sun K, Tan V, Wong AW, Zheng B, Ryerson CJ. Marinescu DC, et al. Among authors: fisher jh. Chest. 2023 Dec;164(6):1466-1475. doi: 10.1016/j.chest.2023.07.068. Epub 2023 Aug 2. Chest. 2023. PMID: 37541339
Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response.
Zheng B, Marinescu DC, Hague CJ, Muller NL, Murphy D, Churg A, Wright JL, Al-Arnawoot A, Bilawich AM, Bourgouin P, Cox G, Durand C, Elliot T, Ellis J, Fisher JH, Fladeland D, Grant-Orser A, Goobie GC, Guenther Z, Haider E, Hambly N, Huynh J, Johannson KA, Karjala G, Khalil N, Kolb M, Leipsic J, Lok S, MacIsaac S, McInnis M, Manganas H, Marcoux V, Mayo J, Morisset J, Scallan C, Sedlic T, Shapera S, Sun K, Tan V, Wong AW, Ryerson CJ. Zheng B, et al. Among authors: fisher jh. Rheumatology (Oxford). 2024 Feb 9:keae076. doi: 10.1093/rheumatology/keae076. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38336872
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort.
Marcoux V, Lok S, Mondal P, Assayag D, Fisher JH, Shapera S, Morisset J, Manganas H, Fell CD, Hambly N, Cox PG, Kolb M, Gershon AS, To T, Sadatsafavi M, Khalil N, Wong AW, Wilcox PG, Ryerson CJ, Johannson KA. Marcoux V, et al. Among authors: fisher jh. J Thorac Dis. 2023 May 30;15(5):2517-2527. doi: 10.21037/jtd-22-1820. Epub 2023 May 12. J Thorac Dis. 2023. PMID: 37324076 Free PMC article.
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study.
Khor YH, Schulte M, Johannson KA, Marcoux V, Fisher JH, Assayag D, Manganas H, Khalil N, Kolb M, Ryerson CJ; Austin ILD Registry and CARE-PF Investigators; ALLIANCE Study Group; Cox G, Fell CD, Gershon AS, Goh N, Halayko AJ, Lok S, Morisset J, Sadatsafavi M, Shapera S, To T, Wilcox PG, Wong AW. Khor YH, et al. Among authors: fisher jh. Eur Respir J. 2023 May 5;61(5):2202163. doi: 10.1183/13993003.02163-2022. Print 2023 May. Eur Respir J. 2023. PMID: 36858445
255 results